The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran
Background: One of the major causes of liver-related mortality and morbidity is Hepatitis C Virus (HCV) infection. It is also one of the reasons behinds of chronic liver disease and related complications such as cirrhosis and hepatocellular carcinoma. This autoimmune liver disease imposes a high eco...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2018-10-01
|
| Series: | Iranian Journal of Public Health |
| Subjects: | |
| Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/14928 |
| _version_ | 1818983881108357120 |
|---|---|
| author | Mehdi MOHAMMADZADEH Hamid DERAFSHI Tayebeh GHARI |
| author_facet | Mehdi MOHAMMADZADEH Hamid DERAFSHI Tayebeh GHARI |
| author_sort | Mehdi MOHAMMADZADEH |
| collection | DOAJ |
| description | Background: One of the major causes of liver-related mortality and morbidity is Hepatitis C Virus (HCV) infection. It is also one of the reasons behinds of chronic liver disease and related complications such as cirrhosis and hepatocellular carcinoma. This autoimmune liver disease imposes a high economic burden on individuals and the society. This study aimed to estimate burden of HCV in Iran.
Methods: Overall, 200 patients with HCV infection, referred to hospitals in three cities of Tehran, Karaj and Tabriz, Iran during year 2015, were randomly enrolled. To estimate the total burden of hepatitis, direct and indirect costs, costs of DALYs and social welfare were calculated.
Results: Economic burden of HCV infection was obtained 26242.8 purchasing power parity (PPP$). Intangible costs of HCV was calculated 207421.6 PPP$.
Conclusion: Total direct costs of HCV for each patient are more than household consumption expenditure. Therefore, it is a reasonable policy to control and increase insurance coverage of HCV patients in order to decrease their costs. |
| first_indexed | 2024-12-20T18:10:09Z |
| format | Article |
| id | doaj.art-9e29475122d54e9883ffdbe170a2acfb |
| institution | Directory Open Access Journal |
| issn | 2251-6085 2251-6093 |
| language | English |
| last_indexed | 2024-12-20T18:10:09Z |
| publishDate | 2018-10-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | Iranian Journal of Public Health |
| spelling | doaj.art-9e29475122d54e9883ffdbe170a2acfb2022-12-21T19:30:29ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852251-60932018-10-014710The Estimation of Economic Burden of Hepatitis C Virus Infection in IranMehdi MOHAMMADZADEH0Hamid DERAFSHI1Tayebeh GHARI2Dept. of Pharmacoeconomy and Administrative Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Pharmacoeconomy & Medical-Pharma Management Research Center, Tehran, IranDept. of Ophthalmology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran AND Dept. of Ophthalmology, School of Medicine, Iran University of Medical Sciences, Tehran, IranPharmacoeconomy & Medical-Pharma Management Research Center, Tehran, Iran AND Dept. of Pharmaceutics, School of Pharmacy, Alborz University of Medical Sciences, Karaj, IranBackground: One of the major causes of liver-related mortality and morbidity is Hepatitis C Virus (HCV) infection. It is also one of the reasons behinds of chronic liver disease and related complications such as cirrhosis and hepatocellular carcinoma. This autoimmune liver disease imposes a high economic burden on individuals and the society. This study aimed to estimate burden of HCV in Iran. Methods: Overall, 200 patients with HCV infection, referred to hospitals in three cities of Tehran, Karaj and Tabriz, Iran during year 2015, were randomly enrolled. To estimate the total burden of hepatitis, direct and indirect costs, costs of DALYs and social welfare were calculated. Results: Economic burden of HCV infection was obtained 26242.8 purchasing power parity (PPP$). Intangible costs of HCV was calculated 207421.6 PPP$. Conclusion: Total direct costs of HCV for each patient are more than household consumption expenditure. Therefore, it is a reasonable policy to control and increase insurance coverage of HCV patients in order to decrease their costs.https://ijph.tums.ac.ir/index.php/ijph/article/view/14928Hepatitis C, Economic burden of disease, Direct and indirect costs, DALYs, Iran |
| spellingShingle | Mehdi MOHAMMADZADEH Hamid DERAFSHI Tayebeh GHARI The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran Iranian Journal of Public Health Hepatitis C, Economic burden of disease, Direct and indirect costs, DALYs, Iran |
| title | The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran |
| title_full | The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran |
| title_fullStr | The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran |
| title_full_unstemmed | The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran |
| title_short | The Estimation of Economic Burden of Hepatitis C Virus Infection in Iran |
| title_sort | estimation of economic burden of hepatitis c virus infection in iran |
| topic | Hepatitis C, Economic burden of disease, Direct and indirect costs, DALYs, Iran |
| url | https://ijph.tums.ac.ir/index.php/ijph/article/view/14928 |
| work_keys_str_mv | AT mehdimohammadzadeh theestimationofeconomicburdenofhepatitiscvirusinfectioniniran AT hamidderafshi theestimationofeconomicburdenofhepatitiscvirusinfectioniniran AT tayebehghari theestimationofeconomicburdenofhepatitiscvirusinfectioniniran AT mehdimohammadzadeh estimationofeconomicburdenofhepatitiscvirusinfectioniniran AT hamidderafshi estimationofeconomicburdenofhepatitiscvirusinfectioniniran AT tayebehghari estimationofeconomicburdenofhepatitiscvirusinfectioniniran |